{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=microRNA&page=4", "query": { "intervention": "microRNA", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 139, "total_pages": 14, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=microRNA&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=microRNA&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-06T21:29:52.678Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02459106", "title": "Effect of AT-derived miRNA on the Biology and Insulin Sensitivity of Skeletal Muscle in Humans", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [], "intervention_types": [], "sponsor": "AdventHealth Translational Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 46, "start_date": "2015-05-27", "completion_date": "2024-12-19", "has_results": false, "last_update_posted_date": "2025-03-07", "last_synced_at": "2026-11-06T21:29:52.678Z", "location_count": 1, "location_summary": "Orlando, Florida", "locations": [ { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02459106" }, { "nct_id": "NCT00565903", "title": "Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pleuropulmonary Blastoma", "Cystic Nephroma", "Sertoli-Leydig Cell Tumor of Ovary", "Medulloepithelioma", "Embryonal Rhabdomyosarcoma of Cervix", "Goiter", "Sarcoma", "Pineoblastoma", "Pituitary Tumors", "Wilms Tumor" ], "interventions": [], "intervention_types": [], "sponsor": "Ashley Hill", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "1 Day", "maximum_age": "95 Years", "sex": "ALL", "summary": "1 Day to 95 Years" }, "enrollment_count": 1247, "start_date": "2005-03", "completion_date": "2022-12-31", "has_results": false, "last_update_posted_date": "2023-03-01", "last_synced_at": "2026-11-06T21:29:52.678Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00565903" }, { "nct_id": "NCT01247597", "title": "DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pleuropulmonary Blastoma", "Cystic Nephroma", "Ovarian Sertoli-Leydig Cell Tumors", "Ocular Medulloepithelioma", "Nasal Chondromesenchymal Hamartoma" ], "interventions": [], "intervention_types": [], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "1 Month", "maximum_age": "99 Years", "sex": "ALL", "summary": "1 Month to 99 Years" }, "enrollment_count": 1500, "start_date": "2011-02-13", "completion_date": null, "has_results": false, "last_update_posted_date": "2026-11-05", "last_synced_at": "2026-11-06T21:29:52.678Z", "location_count": 2, "location_summary": "Bethesda, Maryland • Rockville, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Rockville", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01247597" }, { "nct_id": "NCT05880914", "title": "Precision Medicine Approaches to Renal Osteodystrophy", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Renal Osteodystrophy", "Chronic Kidney Diseases", "CKD-MBD", "Bone Turnover Rate Disorder", "Secondary Hyperparathyroidism" ], "interventions": [ { "name": "miRNAseq analysis", "type": "PROCEDURE" }, { "name": "Standard treatment for bone disorder", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "Thomas Nickolas", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2022-12-21", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-06-12", "last_synced_at": "2026-11-06T21:29:52.678Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05880914" }, { "nct_id": "NCT04217850", "title": "microRNA Testing for Identification of Personalized Weight Management", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Overweight and Obesity", "Weight Loss" ], "interventions": [ { "name": "250 kcal Dietary Energy Restriction", "type": "OTHER" }, { "name": "Aerobic Exercise", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "North Dakota State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 26, "start_date": "2020-01-13", "completion_date": "2020-06-30", "has_results": false, "last_update_posted_date": "2022-05-31", "last_synced_at": "2026-11-06T21:29:52.678Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04217850" }, { "nct_id": "NCT06342440", "title": "Early Detection of Advanced Adenomas and Colorectal Cancer", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Colorectal Cancer", "Colorectal Neoplasms", "Colorectal Polyp", "Colorectal Adenocarcinoma", "Colorectal Disorders", "Colorectal Dysplasia", "Colorectal Cancer Stage I", "Colorectal Cancer Stage II", "Colorectal Cancer Stage III", "Colorectal Cancer Stage IV", "Colorectal Neoplasms Malignant", "Colorectal Serrated Adenocarcinoma", "Colorectal Adenoma With Severe Dysplasia", "Colorectal Adenoma With Mild Dysplasia", "Colorectal Adenoma With Moderate Dysplasia", "Colorectal Adenoma and Carcinoma 1", "Colorectal Adenomatous Polyp", "Colorectal Adenocarcinoma Metastatic in the Liver" ], "interventions": [ { "name": "DENEB", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2000, "start_date": "2020-03-15", "completion_date": "2028-06-18", "has_results": false, "last_update_posted_date": "2026-07-07", "last_synced_at": "2026-11-06T21:29:52.678Z", "location_count": 2, "location_summary": "Monrovia, California • San Diego, California", "locations": [ { "city": "Monrovia", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06342440" }, { "nct_id": "NCT01631760", "title": "Identification of Plasma miRNAs as Potential Biomarkers in Asthma Exacerbation", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Asthma" ], "interventions": [ { "name": "no intervention", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "University of South Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "5 Years to 85 Years" }, "enrollment_count": 0, "start_date": "2011-10", "completion_date": null, "has_results": false, "last_update_posted_date": "2014-10-07", "last_synced_at": "2026-11-06T21:29:52.678Z", "location_count": 2, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01631760" }, { "nct_id": "NCT05868226", "title": "PRE-ISPY Phase I/II Oncology Platform Program", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "HER2-positive Breast Cancer", "Metastatic Cancer", "Metastatic Breast Cancer", "Metastatic", "HER2-positive Metastatic Breast Cancer", "HER2 Mutation-Related Tumors", "HER-2 Protein Overexpression", "HER2-negative Breast Cancer", "Triple Negative Breast Cancer", "HR Positive", "Hormone Receptor-positive Breast Cancer", "Estrogen Receptor Positive Tumor", "Progesterone Receptor-positive Breast Cancer", "Hormone Receptor Negative Breast Carcinoma", "Solid Tumor", "Solid Tumor, Adult", "Solid Carcinoma", "HER2 Low Breast Cancer", "HER2 Low Breast Carcinoma", "ER Positive Breast Cancer", "PR-positive Breast Cancer", "Minimal Residual Disease", "Colo-rectal Cancer", "Colon Cancer", "Rectal Cancer", "ctDNA Monitoring", "Colorectal Neoplasms", "Colonic Neoplasms", "Rectal Neoplasms", "Neoplasm, Residual", "Adenocarcinoma of Colon", "Adenocarcinoma" ], "interventions": [ { "name": "ALX148", "type": "DRUG" }, { "name": "Fam-Trastuzumab Deruxtecan-Nxki", "type": "DRUG" }, { "name": "Zanidatamab", "type": "DRUG" }, { "name": "Tucatinib", "type": "DRUG" }, { "name": "TTX-MC138", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "QuantumLeap Healthcare Collaborative", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 280, "start_date": "2023-02-15", "completion_date": "2031-12-30", "has_results": false, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-11-06T21:29:52.678Z", "location_count": 10, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Aurora, Colorado + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Tampa", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05868226" }, { "nct_id": "NCT02323984", "title": "Postoperative Delirium in Hip Arthroplasty Patients", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Delirium", "Postoperative Complications" ], "interventions": [ { "name": "miRNA Testing, Microemboli Monitoring, Delirium Assessment", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "30 Years to 80 Years" }, "enrollment_count": 49, "start_date": "2014-01", "completion_date": "2016-03", "has_results": false, "last_update_posted_date": "2017-01-20", "last_synced_at": "2026-11-06T21:29:52.678Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02323984" }, { "nct_id": "NCT07224802", "title": "Forecasting Occult liveR Metastasis Using an Exosomal Signature for Intelligent Guided Hepatic Targeting", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "PDAC - Pancreatic Ductal Adenocarcinoma" ], "interventions": [ { "name": "EXELiM assay (qRT-PCR validation)", "type": "DIAGNOSTIC_TEST" }, { "name": "EXELiM small RNA sequencing", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 372, "start_date": "2024-06-21", "completion_date": "2026-02-18", "has_results": false, "last_update_posted_date": "2026-03-13", "last_synced_at": "2026-11-06T21:29:52.678Z", "location_count": 1, "location_summary": "Duarte, California", "locations": [ { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07224802" } ] }